1-(4-((2-fluorobenzyl)oxy)phenyl)-3-(((2R,3S,5S)-3-hydroxy-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl)urea |
|
2',3'-dideoxycarbocyclic |
|
2′,3′ dideoxycarbocyclic derivative of thymidine
|
|
2'-deoxy-5-aza-cytidylyl-(3'->5')-2'-deoxy-guanosine
|
|
3'-azido-2',3'-deoxythymidine |
|
3'-deoxyguanosine-5' -monophosphate
|
|
3'-o-p-toluoyl-5'-o-diphenylacetyl-β-thymidine |
|
5'- azido-5’-deoxy-α-thymidine
|
|
5′-phenyl (thio)urea
|
|
5-fluoro-2'-deoxyuridine
|
|
5'-o-diphenylacetyl-β-thymidine |
|
5'-o-methanesulfonyl-α-thymidine |
|
5'-urea-α-thymidine |
|
aurantiamide acetate
|
|
Biochem characterization, suggested target |
|
Chlorobenzyloxy)phenyl)urea
|
|
Ganciclovir
|
|
In silico, suggested target
|
|
Mutational, inhibitory and microcalorimetric analyses, suggested target |
|
N-(5′-deoxy-α-thymidin-5′-yl)
|
|
P1 -(5 -adenosyl)-p5 -(5 - thymidyl) pentaphosphate
|
|
Peehx
|
|
Pyrimidine based inhibitors suggested target
|
|
Thymidine
|
|